About Spry Therapeutics Private Limited
Data last updated:
Spry Therapeutics Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Spry Therapeutics Inc. and recognised as a startup by DPIIT. It operates in the wellness and healthcare centers segment of the travel and hospitality sector. It was incorporated on 29 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2021PTC359727. Its GSTIN is 27ABGCS0029M1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijraj Bhuptani and Riyaz Rehman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.15 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹2.35 Cr (net margin 7.8%) and EBITDA of ₹3.5 Cr (EBITDA margin 11.6%). Revenue has grown at a compounded annual rate (CAGR) of 132% over three years.
The company has about 64 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SPRY.
For more details, the company can be reached via its website sprypt.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address18 Sangam B Wing Four Bunglows Haridwar Marg North Mumbai Suburban, Maharashtra, India – 400061
- IndustryTravel and Hospitality, Wellness & Healthcare Centers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Spry Therapeutics Private Limited
Spry Therapeutics operates one associated brand: SPRY. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Cloud-based practice management is provided for physical therapy clinics. | sprypt.com |
Competitors & Alternatives of Spry Therapeutics Private Limited
Brands and companies operating in the same space as Spry Therapeutics Private Limited include Clinicient, Prompt, WebPT and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Clinicient | Cloud Platform for revenue and clinical documentation management for outpatient rehabilitation clinics | Portland, United States | 1998 |
 Prompt | EMR software is provided for physical therapy clinics. | Hackensack, United States | 2017 |
 WebPT | Cloud based SaaS platform of EMR for PTs, OTs and SLPs | Phoenix, United States | 2008 |
 Digital Darwin | AI-powered tools for health, sports, and physical wellness are developed. | Delhi, India | 2021 |
 Healthy Roster | Sports training and EMR platform provided for physical therapists. | Dublin, United States | 2015 |
 TheraOffice | EMR and practice management software for physical therapists is developed. | Westmont, United States | 1999 |
 HENO | Cloud-based practice management software for therapists is offered. | Orlando, United States | 2016 |
 HealthSpark | Administrative tasks for physical therapy practices are streamlined by AI. | San Francisco, United States | 2024 |
Business Activity of Spry Therapeutics Private Limited
The main business activity of Spry Therapeutics is information and communication. In detail, this covers other information & communication service activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Spry Therapeutics Private Limited
Spry Therapeutics Private Limited is audited by Manohar Chowdhry & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Manohar Chowdhry & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Spry Therapeutics Private Limited
Spry Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijraj Bhuptani Also directs: Veex Tech Solution India Private Limited | Director | 29 Apr 2021 | 5 Years 5 Months | Current |
| Riyaz Rehman Also directs: Design Bytes Private Limited | Director | 29 Apr 2021 | 5 Years 5 Months | Current |
Financials of Spry Therapeutics Private Limited FY 2025 filings available
Spry Therapeutics Private Limited reported revenue of ₹30.15 Cr (up 86% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Spry Therapeutics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 132% over three years, including 86% growth in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Spry Therapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.5 Cr | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.35 Cr | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Spry Therapeutics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 11.6% | •••• | •••• | •••• |
| Net Profit Margin | 7.8% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spry Therapeutics are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Spry Therapeutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Spry Therapeutics Private Limited
Spry Therapeutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Spry Therapeutics Private Limited
Spry Therapeutics Private Limited has a workforce of 64 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Spry Therapeutics Private Limited
Spry Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABGCS0029M1Z6 | Maharashtra | Active | 11 Jun 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Spry Therapeutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Spry Therapeutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Spry Therapeutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Spry Therapeutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Spry Therapeutics Private Limited
Frequently Asked Questions about Spry Therapeutics Private Limited
Spry Therapeutics is an active private limited company based in Mumbai, Maharashtra, India. The company works in wellness and healthcare centers, within the travel and hospitality industry. It was incorporated on 29 April 2021 (5+ years old) and is registered under CIN U85300MH2021PTC359727.
Spry Therapeutics reported revenue of ₹30.15 Cr for FY 2025 (up 86% YoY).
Spry Therapeutics has 2 current directors:
- Brijraj Bhuptani - Director
- Riyaz Rehman - Director
Spry Therapeutics reported a net profit of ₹2.35 Cr (net margin 7.8%) and EBITDA of ₹3.5 Cr (EBITDA margin 11.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Spry Therapeutics is 132% over three years. In the latest year (FY 2025) revenue rose 86%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Spry Therapeutics is 27ABGCS0029M1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Spry Therapeutics is U85300MH2021PTC359727. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spry Therapeutics was incorporated on 29 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Yes, Spry Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).